$70 Tucatinib 150mg Tablets 60 caps

Tucatinib is an inhibitor designed for HER2-positive breast cancer patients with brain metastases, which effectively blocks HER2 signaling. The tablet forms are available in 50 mg and 150 mg, with the recommended dosage being 300 mg taken twice daily and administered with food. Each bottle comes with 60 of these tablets.

They’ve set up the dosage plan to help it work best against certain breast cancers that spread to the brain. They go the extra mile to make sure the total daily dose is about 600 mg, which is just the right amount for patients who need it.